BEBT-109
BEBT-109 is a potent pan-mutant-selective EGFR inhibitor. BEBT-109 has improved pharmacokinetic properties. BEBT-109 can be used for multiple mutant-EGFR-driven non-small cell lung cancer (NSCLC) research[1].
Product Specifications
CAS Number
[2050906-40-4]
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
EGFR
Type
Reference compound
Related Pathways
JAK/STAT Signaling; Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/bebt-109.html
Concentration
10mM
Purity
98.72
Solubility
DMSO : 33.33 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
C=CC(NC1=CC(NC2=NC=CC(N3C=CC4=NC(OC)=CC=C43)=N2)=C(OC)C=C1N(CCN(C)C)C)=O
Molecular Formula
C27H32N8O3
Molecular Weight
516.59
Precautions
H302, H315, H319, H335
References & Citations
[1]Fan F, et al BEBT-109, a pan-mutant-selective EGFR inhibitor with potent antitumor activity in EGFR-mutant non-small cell lung cancer. Transl Oncol. 2021 Feb;14 (2) :100961.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6004077-01 0.1 mL
GTF2H4 (General Transcription Factor IIH Subunit 4, Basic Transcription Factor 2 52 kDa Subunit, BTF2 p52, General Transcription Factor IIH Polypeptide 4, TFIIH Basal Transcription Factor Complex p52 Subunit)
Ask
View Details 
MBS6004077-02 5x 0.1 mL
GTF2H4 (General Transcription Factor IIH Subunit 4, Basic Transcription Factor 2 52 kDa Subunit, BTF2 p52, General Transcription Factor IIH Polypeptide 4, TFIIH Basal Transcription Factor Complex p52 Subunit)
Ask
View Details 
GTR15203990 1 Vial
Lentiviral mouse Fbxw13 shRNA (UAS) - Lentiviral mouse Fbxw13 shRNA (UAS, iRFP) (25)
Ask
View Details